Le Lézard
Classified in: Health, Covid-19 virus
Subjects: TRI, PSF

Respiratory Effectiveness Group: Exemptions of respiratory patients to use face masks are not evidence-based, and it may carry associated risks of severe COVID-19


LITTLEPORT, England, Sept. 30, 2020 /PRNewswire/ -- There have been many false health news, hoaxes and biased information about the ongoing COVID-19 pandemic circulating on the net, and also in printed media and on TV. However, sometimes confusion and misinformation occur through official channels. And it can have serious consequences.

One of them is the exemption for respiratory patients to use a facemask, mandatory elsewhere for everyone both in shared outdoor and indoor spaces since May 2020. The Spanish and British laws state: "Those persons who present some type of respiratory difficulty that may be aggravated by the use of the mask, and those whose use is contraindicated for health or disability reasons, are excepted from this obligation."

At the Respiratory Effectiveness Group (REG at https://www.regresearchnetwork.org/), an independent global group of medical doctors and researchers in Spain, the United Kingdom and many of the EU member states, the United States, Canada and Australia, among others, have reviewed the available evidence.

In an article published today in the European Respiratory Journal (accessible from https://doi.org/10.1183/13993003.03325-2020), one of the most prestigious international journals in the respiratory arena, it was concluded that there is no evidence to support this exception, and that patients with a respiratory disease are at a high risk of suffering severe COVID-19, in Spain, the UK and elsewhere. We must succeed in eliminating this exception.

Dr Joan B Soriano, medical epidemiologist at the Respiratory Dept. of Hospital La Princesa in Madrid, Spain, member of the WHO COVID-19 Clinical Network Knowledge Exchange Team, and primary author stated: "Patients with asthma, COPD or other respiratory diseases should wear the mask without exceptions. If they have respiratory failure or with a feeling of shortness of breath when putting it on, they should most likely limit their activity, especially outdoors."

Not using a mask to avoid an asthma attack, or exacerbations of COPD, or of other respiratory diseases, due to an alleged increase in inspiratory pressures through a mask, is unfounded.

Professor Sinthia Bosnic-Anticevich, from the Woolcock Institute at The University of Sydney, who is President of REG and also co-author, also stated: "Please, if you or a relative of yours, have asthma, COPD or other chronic respiratory disease, wear a mask to protect yourself and others. This is a new virus and a new disease, but clear information and individual decisions are critical to defeating this pandemic."

It is estimated there are 545 million people worldwide suffering a chronic respiratory disease, and not wearing a face mask may carry increased risk of personal and group infection.

More information from:
Michael Walker
CEO REG
Email: michael@regresearchnetwork.org

Note: full citation as:
Soriano JB, Anzueto A, Bosnic Anticevich S, et al. Face masks, respiratory patients and COVID-19. Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.03325-2020).


These press releases may also interest you

at 16:45
Aptinyx Inc. , a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced positive results from the first Phase 2 study of its novel NMDA receptor modulator,...

at 16:35
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has received a request for additional information from the U.S. Food and Drug Administration (the "FDA" or...

at 16:30
Invesque Inc. (the "Company") will release its fiscal 2020 third quarter results on Wednesday, November 11, 2020 after markets close. Management of the Company will hold a conference call at 10:00 a.m. ET on Thursday, November 12, 2020 to review...

at 16:30
Stealth BioTherapeutics , a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that the company will have a poster at...

at 16:29
StageZero Life Sciences Ltd. ("StageZero", or the "Company"), is pleased to announce that it has filed a preliminary short form prospectus (the "Prospectus") with the securities commissions in the Provinces of British Columbia, Alberta, and Ontario...

at 16:25
LabCorp , a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Swedish, the largest nonprofit healthcare system in the Puget Sound region, today announced an agreement to extend their more...



News published on 30 september 2020 at 02:00 and distributed by: